Key insights from EBMT 2025, including trends in CAR-T, JACIE developments, and the growing demand for contingency services in cell therapy. Read Biovault’s perspective on what’s shaping the future of the field.
Key insights from EBMT 2025, including trends in CAR-T, JACIE developments, and the growing demand for contingency services in cell therapy. Read Biovault’s perspective on what’s shaping the future of the field.
Ensure accurate CFU/gm testing for your cell therapy laboratory. Biovault Technical provides reliable and consistent assays, helping you maintain cell quality and focus on your core work.
Discover how Biovault supports oncologists and haematologists with bespoke stem cell processing, storage and logistics services for regenerative cellular therapies.
The MHRA has granted Biovault Technical a WDA license, enabling the distribution of medicinal products and advancing cell therapy access in Plymouth and the UK.
